Navigation Links
AcceleDent System From OrthoAccel Technologies, Inc. Secures Medical Device Regulatory Clearance to Market in Australia

HOUSTON, Nov. 11 /PRNewswire/ -- OrthoAccel Technologies, Inc., developers of the AcceleDent System, which is an acceleration device to enhance orthodontics, announced that its application to market and distribute the product for sale was approved by Australia's Therapeutic Goods Administration (TGA). AcceleDent is classified as an, "orthodontic appliance system," in Australia.



AcceleDent is a simple, removable dental device that patients wear in the mouth for twenty minutes daily. It generates a light microvibration force which modulates the bone tissue remodeling process and accelerates orthodontic tooth movement. The device is hands-free and allows the user flexibility to carry out most routine tasks during the twenty-minute use session. The first case in private practice was initiated last month in the United Kingdom, OrthoAccel's first commercial market.

Brent Tarver, VP Clinical Affairs at OrthoAccel, remarked, "We consider this regulatory clearance to be an important part of our strategic plans, particularly as we begin focusing on the conclusion of the pivotal trial next year for FDA clearance here in the United States." AcceleDent has been added to the Australian Register of Therapeutic Goods (ARTG). Mike Kaufman, VP Business Development at OrthoAccel, added, "We will be attending the World Federation of Orthodontists 7th International Orthodontic Congress in February next year in Sydney. Australia is a progressive orthodontic market that is very open to credible and meaningful new technologies."

Results from the initial clinical trial demonstrated an overall tooth movement rate of 2.1 mm per month, which is 30% to 50% faster than what is reported in the literature. This same study further demonstrated the safety of the AcceleDent System through a detailed measurement and statistical analysis of root resorption, yielding mean values of below 0.5 mm. It should be noted that 0.5 mm is well below the level of 2 mm, or one-third of the root length, considered clinically significant by researchers.

Jeremy J. Mao, DDS, PhD is the original inventor of the core OrthoAccel technology and also currently serves as the Chairman of the Company's Scientific Advisory Board. He commented, "The Phase I Human Clinical Trial conducted at the University of Texas Dental Branch in Houston validates our previously published animal data that serves as the foundation for the concept that orthodontic treatment can be safely accelerated." Dr. Mao also serves as the Director of the Tissue Engineering & Regenerative Medicine Laboratory and Professor at the Columbia University College of Dental Medicine in New York.

OrthoAccel is presently controlling availability of AcceleDent in the United Kingdom to a select group of orthodontic specialists before a broader release in October 2010. The Company reports plans to take a similar approach with the Australian market.

About OrthoAccel Technologies, Inc.

Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.

About the AcceleDent System

AcceleDent represents the first clinical approach to safely accelerate orthodontic tooth movement via modulating biology. The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling. Importantly, the device works complementary with all existing orthodontic technologies. AcceleDent is neither FDA cleared nor FDA approved; it is currently investigational only in the United States. More information can be found at or requested via

    Media Contact  Michael K. Lowe, CEO  +(832) 631-1659

SOURCE OrthoAccel Technologies, Inc.

SOURCE OrthoAccel Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Different method of evaluating the urinary tract system reduces radiation dose
2. Lutheran Senior Services Partners with Silverchair Learning Systems to Enhance Employee Training and Education
3. Exempla Healthcare Contracts For Talismans Quality Donor System
4. Heartline(R) Fitness Systems Named to Inc. Magazines Inaugural List of the 5000 Fastest Growing Private Companies in U.S....
5. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
6. Plexus Systems Ranks in Top Third of the 2007 Inc. 5,000 with Three-Year Sales Growth of 226%
7. Document Security Systems (Amex: DMC) Invites You to a Landmark Event
8. Flu Vaccinations Begin on September 29 Maxim Health Systems to Provide 24,000 Flu Shot Clinics Nationwide
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
11. NAMSA Deploys TrackWise Software as its Quality Management System
Post Your Comments:
(Date:11/28/2015)... (PRWEB) , ... November 28, 2015 , ... ... exchange technology and teleradiology services, has added Chris Hafey and Claude Hooton to ... at the Radiological Society of North America (RSNA) 2015 Annual Meeting and continues ...
(Date:11/28/2015)... ... 2015 , ... Pixel Film Studios is back again with ProPanel: Pulse ... are endless. Users have full control over angle of view, speed method, start point, ... sure to get heads to turn. , ProPanel: Pulse offers fully customizable pulsating shape ...
(Date:11/27/2015)... Denver, CO (PRWEB) , ... November 27, 2015 , ... ... U.S. cities are not changing the way that they are handling security in light ... increasing police and security presence in an attempt to stop an attack from reaching ...
(Date:11/27/2015)... ... 2015 , ... "When I was traveling, I was very ... "Many people catch diseases simply from sitting on such dirty toilet seats. I ... germs." , He developed the patent-pending QUDRATECS to eliminate the need to sit ...
(Date:11/27/2015)... ... 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% ... More than 3.7 billion people under the age of 50 – or 67% of the ... first global estimates of HSV-1 infection . , "The data shocks us highly!" said ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Cell Surface Marker Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
(Date:11/25/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... the United States (U.S.) Food ... candidate to Humira ® (adalimumab). Amgen believes this ... the FDA and represents Amgen,s first BLA submission using ... , M.D., executive vice president of Research and Development ...
(Date:11/25/2015)... 25, 2015 AAIPharma Services Corp./Cambridge Major ... at least $15.8  Million to expand its laboratories ... . The expansion will provide additional office ... growing demands of the pharmaceutical and biotechnology markets. ... will provide up to 40,000 square feet of ...
Breaking Medicine Technology: